4//SEC Filing
Nayak Sanjay 4
Accession 0001104659-25-053094
CIK 0001393434other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:42 PM ET
Size
5.7 KB
Accession
0001104659-25-053094
Insider Transaction Report
Form 4
Nayak Sanjay
Chief Strategy Officer
Transactions
- Sale
Common Stock
2025-05-23$7.17/sh−1,862$13,351→ 281,623 total
Footnotes (2)
- [F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2025. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.06 to $7.28, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0002012715
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:42 PM ET
- Size
- 5.7 KB